Radiation plus concurrent nimotuzumab versus CDDP in locally advanced nasopharyngeal cancer: Results of a phase III randomised trial.

被引:7
|
作者
Kong, Lin
Lin, Qin
Hu, Chaosu
Xu, Tingting
Liao, Xiyi
Shen, Chunying
Lu, Jiade J.
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Proton & Heavy Ion Ctr, Shanghai, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China
关键词
D O I
10.1200/JCO.2016.34.15_suppl.6002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6002
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Radiotherapy alone versus concurrent chemoradiotherapy in intermediate risk nasopharyngeal carcinoma: A multicentre, open-label, noninferiority, randomised phase III trial.
    Ma, Jun
    Tang, Ling-Long
    Guo, Rui
    Zhang, Ning
    Deng, Bin
    Zhang, Yuan
    Huang, Jing
    Zhou, Guan-Qun
    Hu, Weihan
    Mao, Yan-Ping
    Li, Wen-Fei
    Liu, Qing
    Xie, Fangyun
    Sun, Ying
    Chen, Lei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Randomized phase III trial of concurrent chemoradiation with or without neoadjuvant gemcitabine, carboplatin, and paclitaxel in locally advanced nasopharyngeal cancer.
    Tan, Terence
    Lim, Wan-Teck
    Fong, Kam-Weng
    Cheah, Shie-Lee
    Soong, Yoke-Lim
    Ang, Mei-Kim
    Ng, Quan Sing
    Tan, Daniel Shao-Weng
    Ong, Whee Sze
    Tan, Sze Huey
    Yip, Connie Slew Poh
    Quah, Daniel
    Soo, Khee Chee
    Wee, Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] Phase II study of concurrent chemoradiotherapy with weekly CDDP/PTX in patients with locally advanced uterine cervical cancer: JACCRO-GY-01 trial.
    Takekuma, Munetaka
    Hirashima, Yasuyuki
    Umayahara, Kenji
    Noda, Shin-ei
    Ohno, Tatsuya
    Miyagi, Etsuko
    Hirahara, Fumiki
    Hirata, Eiji
    Kondo, Eiji
    Tabata, Tsutomu
    Nagai, Yutaka
    Aoki, Yoichi
    Wakatsuki, Masaru
    Takeuchi, Masahiro
    Toita, Takafumi
    Takeshima, Nobuhiro
    Takizawa, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Radiotherapy versus cryotherapy for locally advanced prostate cancer: Preliminary results of a randomized trial.
    Bauman, G
    Chin, J
    Downey, D
    Radwan, J
    Venkatesan, VM
    Moussa, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 72 : S52 - S52
  • [25] Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial
    Yang, Qi
    Cao, Su-Mei
    Guo, Ling
    Hua, Yi-Jun
    Huang, Pei-Yu
    Zhang, Xiao-Long
    Lin, Mei
    You, Rui
    Zou, Xiong
    Liu, You-Ping
    Xie, Yu-Long
    Wang, Zhi-Qiang
    Mai, Hai-Qiang
    Chen, Qiu-Yan
    Tang, Lin-Quan
    Mo, Hao-Yuan
    Cao, Ka-Jia
    Qian, Chao-Nan
    Zhao, Chong
    Xiang, Yan-Qun
    Zhang, Xiu-Ping
    Lin, Zhi-Xiong
    Li, Wei-Xiong
    Liu, Qing
    Li, Ji-Bin
    Ling, Li
    Guo, Xiang
    Hong, Ming-Huang
    Chen, Ming-Yuan
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : 87 - 96
  • [26] Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control
    Glynne-Jones, R.
    Counsell, N.
    Quirke, P.
    Mortensen, N.
    Maraveyas, A.
    Meadows, H. M.
    Ledermann, J.
    Sebag-Montefiore, D.
    ANNALS OF ONCOLOGY, 2014, 25 (07) : 1356 - 1362
  • [27] Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial
    Chen, Lei
    Hu, Chao-Su
    Chen, Xiao-Zhong
    Hu, Guo-Qing
    Cheng, Zhi-Bin
    Sun, Yan
    Li, Wei-Xiong
    Chen, Yuan-Yuan
    Xie, Fang-Yun
    Liang, Shao-Bo
    Chen, Yong
    Xu, Ting-Ting
    Li, Bin
    Long, Guo-Xian
    Wang, Si-Yang
    Zheng, Bao-Min
    Guo, Ying
    Sun, Ying
    Mao, Yan-Ping
    Tang, Ling-Long
    Chen, Yu-Ming
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2012, 13 (02): : 163 - 171
  • [28] TPF induction chemotherapy versus PF adjuvant chemotherapy plus concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A multicenter, randomized controlled, III trial.
    He, Qianyong
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Concurrent Chemoradiation Therapy With or Without Nimotuzumab in Locally Advanced Squamous Cell Lung Cancer: A Phase 2 Randomized Trial
    Qiu, Bo
    Wang, DaQuan
    Li, QiWen
    Wu, YingJia
    Guo, SuPing
    Jiang, XiaoBo
    Fang, JianLan
    Guo, JinYu
    Liu, FangJie
    Chu, Chu
    Wang, Bin
    Chen, Li
    Zhang, Jun
    Liu, YiMei
    Hu, YongHong
    Liu, Hui
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 917 - 925
  • [30] A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Agarwal, Jaiprakash
    Ghosh-Laskar, Sarbani
    Budrukkar, Ashwini
    Murthy, Vedang
    Gupta, Tejpal
    Mahimkar, Manoj
    Juvekar, Shashikant
    Arya, Supreeta
    Mahajan, Abhishek
    Agarwal, Archi
    Purandare, Nilendu
    Rangarajan, Venkatesh
    Balaji, Arun
    Chaudhari, Sameer Vasant
    Banavali, Shripad
    Kannan, Sadhana
    Bhattacharjee, Atanu
    D'Cruz, Anil K.
    Chaturvedi, Pankaj
    Pai, Prathamesh S.
    Chaukar, Devendra
    Pantvaidya, Gouri
    Nair, Deepa
    Nair, Sudhir
    Deshmukh, Anuja
    Thiagarajan, Shivakumar
    Mathrudev, Vijayalakshmi
    Manjrekar, Aparna
    Dhumal, Sachin
    Maske, Kamesh
    Bhelekar, Arti Sanjay
    Nawale, Kavita
    Chandrasekharan, Arun
    Pande, Nikhil
    Goel, Alok
    Talreja, Vikas
    Simha, Vijai
    Srinivas, Sujay
    Swami, Rohit
    Vallathol, Dilip Harindran
    Dsouza, Hollis
    Shrirangwar, Sameer
    Turkar, Siddharth
    Abraham, George
    Thanky, Aditi Harsh
    Patel, Usha
    Pandey, Manish Kumar
    CANCER, 2019, 125 (18) : 3184 - 3197